Abstract Details

Title Endpoint for Clinical Trials Involving Patients with Intracerebral Hemorrhage: Modified Rankin Scale as a Dichotomized or Ordinal Outcome

Topic Neuroepidemiology/Health Services and Outcomes Research

Presentation(s) (-)

Poster/Presentation
Number 117

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Yuko Palesch	No disclosure on file
Renee Martin	No disclosure on file
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Michael Alosco, PhD (Boston University)	The institution of Michael Alosco, PhD has received research support from NIH. The institution of Michael Alosco, PhD has received research support from Life Molecular Imaging Inc.

��ɫ��